Business
AI in Drug Discovery Market Research Report 2026-2040: NVIDIA, Insilico Medicine, Google DeepMind, Pfizer, and Roche Leveraging AI Platforms to Accelerate Development Timelines and Reduce R&D Costs
AI in drug discovery offers key market opportunities by enhancing drug development efficiency, reducing costs, and improving success rates. It supports personalized medicine, facilitating custom therapies. The market will grow due to investments, collaboration, and AI's role in addressing rising chronic conditions.Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "AI in Drug Discovery Market, till 2040: Distribution by Drug Discovery Steps, Therapeutic Area, and Key Geographical Regions: Industry Tr
About this update from Pfizer, Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"AI in drug discovery offers key market opportunities by enhancing drug development efficiency, reducing costs, and improving success rates. It supports personalized medicine, facilitating custom therapies. The market will grow due to investments, collaboration, and AI's role in addressing rising chronic conditions.","length":320,"tagName":"p"},{"type":"text","content":"Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "AI in Drug Discovery Market, till 2040: Distribution by Drug Discovery Steps, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering.","length":278,"tagName":"p"},{"type":"text","content":"The global AI in drug discovery market is projected to expand dramatically, from USD 1.81 billion this year to USD 41.08 billion by 2040, growing at a CAGR of 25%.","length":163,"tagName":"p"},{"type":"text","content":"This growth is driven by innovations like virtual screening, predictive modeling, and de novo drug design, which accelerate the drug development process, reduce costs, and boost success rates. Machine learning and deep learning are key technologies, processing vast datasets to identify drug candidates, predict behaviors within the body, and even generate new molecules.","length":371,"tagName":"p"},{"type":"text","content":"The demand for AI in drug discovery is increasing due to the need for advanced therapeutics for chronic conditions. As these diseases become more prevalent, pharmaceutical companies are ramping up R&D investments, further fueling market expansion. AI's ability to repurpose existing drugs and personalize therapies adds another dimension to its transformative potential.","length":378,"tagName":"p"},{"type":"text","content":"Strategic Insights for Senior Leaders Key Growth Drivers","length":...